期刊文献+

局部进展性和转移性肾癌外科治疗现状 被引量:3

Current Status of Surgical Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma
下载PDF
导出
摘要 文章主要阐述了外科手术在治疗局部进展性和转移性肾癌中的价值,分别对区域淋巴结转移、肾上腺转移、静脉瘤栓、邻近器官受侵以及转移灶切除的疗效进行了讨论。
作者 马建辉
出处 《肿瘤学杂志》 CAS 2008年第5期347-351,共5页 Journal of Chinese Oncology
  • 相关文献

参考文献65

  • 1马建辉,何志嵩,万奔,等.肾细胞癌诊治指南[A].那彦群,孙则禹,叶章群,等.中国泌尿外科疾病诊断治疗指南[M].北京:人民卫生出版社,2007.8-29.
  • 2Dekernion JB,Ramming KP,Smith RB.The natural history of metastatic renal cell carcinoma:a computer analysis[J].J Urol,1978,120(2):148-152.
  • 3Motzer RJ,Bander NH,Nanus DM.Renal-cell carcinoma[J].N Engl J Med,1996,335(12):865-875.
  • 4Blute ML,Leibovich BC,Cheville JC,et al.A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma[J].J Urol,2004,172(2):465-469.
  • 5Pantuck AJ,Zisman A,Dorey F,et al.Renal cell carcinoma with retroperitoneal lymph nodes:role of lymph node dissection[J].J Urol,2003,169(6):2076-2083.
  • 6Jocham D,Richter A,Hoffmann L,et al.Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy:phase Ⅲ,randomised controlled trial[J].Lancet,2004,363(9409):594-599.
  • 7Bassil BA,Dosoretz DE,Prout GR.Validation of the tumor,nodes,and metastasis classification of renal cell carcinoma[J].J Urol,1985,134(3):450-454.
  • 8Phillips CK,Taneja SS.The role of lymphadenectomy in the surgical management of renal cell carcinoma[J].Urol Oncol,2004,22(3):214-224.
  • 9Paul R,Mordhorst J,Busch R,et al.Renal sparing surgery during radical nephrectomy in patients with renal cell cancer:a new algrithm[J].J Urol,2001,166(1):59-62.
  • 10Siemer S,Lehmann J,Kamradt J,et al.Adrenal metastases in 1635 patients with renal cell carcinoma:outcome and indication for adrenalectomy[J].J Urol,2004,171(6 Pt 1):2155-2159.

共引文献1

同被引文献22

  • 1张玲燕,汤永民,沈红强,宁铂涛,钱柏芹,石淑文,杨世隆,徐卫群.ABCG2在白血病细胞中的表达及其意义[J].浙江医学,2004,26(11):803-805. 被引量:3
  • 2Negrier S. Better survival with interleukn-2-based regimens? Possibly only in highly selected patients [ J ]. J Clin Oncol, 2004, 22 : 1174 - 1176.
  • 3Pavone L, Andrulli S,Santi R, et al. Long-term treatment with low doses of interleukn-2 and interferon-alpha: immunological effects in advanced renal cell cancer[ J]. Cancer Immunol Immunother, 2001, 50:82-86.
  • 4Culine S, Iborra F, Mottet N, et al. Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma:Results of a French regional experience in Languedoc [ J ]. Am J Clin Oncol, 2006, 29(2) :148 -152.
  • 5Martel CL, Lara PN. Renal cell carcinoma current status and future directions [J].Crit Rev Oncol Hematol, 2003, 45:177 - 190.
  • 6Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced dear-cell renal-cell carcinoma[ J ]. N Engl J Med, 2007, 356: 125 - 134.
  • 7Motzer R J, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma [ J ]. N Engl J Med, 2007,356(2) :115 - 124.
  • 8Hudes G, Cardueci M, Tomczak P, et al. Temsimlimus, interferon alfa, or both for advanced renal-cell carcinoma[J].N Engl J Med, 2007, 356:2271 - 2281.
  • 9Maisey NR, Hall K, Lee C, et al. Infliximab. A phase Ⅱ trial of the tumor necrosis factor(TNFα) monoclonal antibody in patients with advanced renal cell cancer( RCC ) [ J ]. J Clin Oncol,2004, 22 : a4514.
  • 10成波(综述),韩瑞发(审校).肾癌预后分子标记物的研究进展[J].国际泌尿系统杂志,2007,27(5):624-628. 被引量:6

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部